Spectrum of parvovirus B19 infection: Analysis of an outbreak of 43 cases in Cadiz, Spain

被引:15
作者
GarciaTapia, AM
delAlamo, CFG
Giron, JA
Mira, J
delaRubia, F
MartinezRodriguez, A
MartinReina, MV
LopezCaparros, R
Caliz, R
Caballero, MS
Bascunana, A
机构
[1] HOSP UNIV PUERTA DEL MAR, DERMATOL SERV, E-11009 CADIZ, SPAIN
[2] HOSP UNIV PUERTA DEL MAR, HEMATOL SERV, E-11009 CADIZ, SPAIN
[3] HOSP UNIV PUERTA DEL MAR, SERV PEDIAT, E-11009 CADIZ, SPAIN
[4] HOSP UNIV PUERTA DEL MAR, RHEUMATOL SERV, E-11009 CADIZ, SPAIN
[5] HOSP UNIV PUERTA DEL MAR, OBSTET & GYNECOL SERV, E-11009 CADIZ, SPAIN
[6] HOSP UNIV PUERTA DEL MAR, INTERNAL MED SERV, INFECT DIS UNIT, E-11009 CADIZ, SPAIN
关键词
D O I
10.1093/clinids/21.6.1424
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the spring of 1993, an epidemic of infection with human parvovirus B19 occurred in Cadiz, Spain. Evaluation of the 43 patients in whom this diagnosis was confirmed revealed four groups of predominant manifestations: (1) hematologic manifestations in six cases (13.9%), including four of aplastic crisis and two of pancytopenia; (2) dermatologic manifestations in 23 cases (53.4%), including 10 of erythema infectiosum and one of erythema multiforme ampullosum; (3) arthralgias/arthritis in nine cases (20.9%), including two with a chronic course; and (4) infection during pregnancy in three cases (7.0%), including two that ended in abortion. Of the 43 patients, 37.2% presented with fever and adenopathies, and these were the only manifestations in two cases. The appearance of clinical disease correlated with modifications in isotype and serum level of specific antibodies to parvovirus B19; the disappearance of IgM antibodies coincided with the resolution of clinical manifestations. Although their presence did not correlate with the course of the disease, the detection of circulating immune complexes in 81.6% of cases supports the possibility that some manifestations were immune mediated.
引用
收藏
页码:1424 / 1430
页数:7
相关论文
共 62 条
[31]   HUMAN-SERUM PARVOVIRUS - A SPECIFIC CAUSE OF APLASTIC CRISIS IN CHILDREN WITH HEREDITARY SPHEROCYTOSIS [J].
KELLEHER, JF ;
LUBAN, NLC ;
MORTIMER, PP ;
KAMIMURA, T .
JOURNAL OF PEDIATRICS, 1983, 102 (05) :720-722
[32]   RISK OF ADVERSE OUTCOMES OF PREGNANCY AFTER HUMAN PARVOVIRUS B19 INFECTION [J].
KINNEY, JS ;
ANDERSON, LJ ;
FARRAR, J ;
STRIKAS, RA ;
KUMAR, ML ;
KLIEGMAN, RM ;
SEVER, JL ;
HURWITZ, ES ;
SIKES, RK .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) :663-667
[33]   DETECTION OF HUMAN PARVOVIRUS B19 DNA BY USING THE POLYMERASE CHAIN-REACTION [J].
KOCH, WC ;
ADLER, SP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (01) :65-69
[34]  
KOZIOL DE, 1992, INFECT CONT HOSP EP, V13, P343, DOI 10.1086/646542
[35]   PURE RED-CELL APLASIA OF 10 YEARS DURATION DUE TO PERSISTENT PARVOVIRUS-B19 INFECTION AND ITS CURE WITH IMMUNOGLOBULIN THERAPY [J].
KURTZMAN, G ;
FRICKHOFEN, N ;
KIMBALL, J ;
JENKINS, DW ;
NIENHUIS, AW ;
YOUNG, NS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (08) :519-523
[36]  
KURTZMAN GJ, 1988, LANCET, V2, P1159
[37]   CHRONIC BONE-MARROW FAILURE DUE TO PERSISTENT B19-PARVOVIRUS INFECTION [J].
KURTZMAN, GJ ;
OZAWA, K ;
COHEN, B ;
HANSON, G ;
OSEAS, R ;
YOUNG, NS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :287-294
[38]   ERYTHEMA MULTIFORME IN A PATIENT WITH ACUTE HUMAN PARVOVIRUS B19 INFECTION [J].
LOBKOWICZ, F ;
RING, J ;
SCHWARZ, TF ;
ROGGENDORF, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (05) :849-850
[39]  
LYNCH C, 1991, INFECT DIS, V10, P84
[40]  
MINTZER D, 1987, BLOOD, V87, pA124